NCT06637553 (ECCEMPW) is a EARLY_PHASE1 clinical trial of Adlay formula in Dysmucorrhea, sponsored by Taipei Medical University.

Who is sponsoring NCT06637553?

NCT06637553 is sponsored by Taipei Medical University.

What drugs are being tested in NCT06637553?

Interventions in NCT06637553: Adlay formula, Placebo.

What condition does NCT06637553 study?

NCT06637553 studies Dysmucorrhea, Menstrual Pain.

Is NCT06637553 still recruiting?

NCT06637553 is currently completed. Last updated 15 October 2024.

Last reviewed 2024-10-15 · How we verify

NCT06637553: ECCEMPW

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Adlay Extract Formula on Dysmenorrhea in Women

Completed EARLY_PHASE1 Last updated 15 October 2024

What this trial tests

EARLY_PHASE1 trial testing Adlay formula in Dysmucorrhea in 77 participants. Completed in 28 September 2018.

Timeline

14 October 2017

Primary endpoint
30 July 2018

28 September 2018

Quick facts

Lead sponsor	Taipei Medical University
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	77
Start date	14 October 2017
Primary completion	30 July 2018
Estimated completion	28 September 2018
Sites	1 location across Taiwan

Drugs / interventions tested

Adlay formula
Placebo

Conditions studied

Dysmucorrhea — all drugs for Dysmucorrhea →
Menstrual Pain — all drugs for Menstrual Pain →

Sponsor

Taipei Medical University

Who can join

Adults 20 to 40, female only, with Dysmucorrhea or Menstrual Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Due to the Westernization of diet in Taiwan, the risk of many chronic diseases has increased. Some diseases and improper treatments are closely related to menstrual pain and functional impairment in women. Women's menstrual pain can affect daily life and work, and many plant-based extracts have been found to have beneficial effects on alleviating menstrual pain. Therefore, the development of functional health food that can improve menstrual pain is of great significance for health promotion and the market. Coix seed has long been understood to have properties beneficial for menstrual health. Scientific research has demonstrated its effectiveness in alleviating menstrual pain. The primary ingredient, "coix seed extract," has been extensively studied, and its efficacy has been confirmed through numerous clinical and animal experiments. This study aims to scientifically investigate the effect of coix seed compound extract on menstrual pain in women and to understand its underlying mechanism and potential benefits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of Adlay-Based Formula on Pain and Discomfort in Women with Dysmenorrhea: A Randomized Controlled Trial.
Chiang YF, Huang KC, Ali M, Hsia SM. · · 2024 · cited 1× · PMID 39683420 · DOI 10.3390/nu16234026

Verify or expand the search:

Other Taipei Medical University trials

Trials by the same sponsor.

NCT07496658 — Nutritional Status, Nutritional Knowledge and Mental Health Among Indonesian Migrant Workers in Taiwan · not yet recruiting
NCT06930313 — Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC) · NA · not yet recruiting
NCT07349446 — Effects of Circadian-Based Acupressure on Sleep Quality in Nursing Home Residents · NA · not yet recruiting
NCT07259369 — The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality Among Hemodialysis Patients · NA · not yet recruiting
NCT07275372 — Using Virtual Humans to Teach Cognitive Function Assessment to Nursing Students · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06637553 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University
Last refreshed: 15 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06637553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing